EMEA-001970-PIP02-17

Key facts

Active substance
SER-109 (Eubacterial Spores, Purified Suspension, Encapsulated)
Therapeutic area
Infectious diseases
Decision number
P/0390/2018
PIP number
EMEA-001970-PIP02-17
Pharmaceutical form(s)
  • Capsule, hard
  • Oral suspension
Condition(s) / indication(s)
Treatment of Clostridium difficile infection
Route(s) of administration
Oral use
Contact for public enquiries
Seres Therapeutics Netherlands B.V.

E-mail: akurowski@serestherapeutics.com
Tel. +19786044260

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating